Mikhail Gishizky Ph.D

Mikhail Gishizky Ph.D General Information

Biography

Dr. Mikhail Gishizky is a Co-Founder of BioCrypton. He is the Founder and serves as Senior Vice President, Research and Development & Chief Scientific Officer at Trellis Bioscience. Dr.Gishizky is an biotech and pharmaceutical expert and executive with broad experience in biopharmaceutical R&D and technologies that have led to breakthrough drug therapies, such as GLIVEC® and SUTENT®, and molecular diagnostics. Dr.Gishizky was a co-founder of Sugen where he served for 18 years in various positions including Vice President Research and Target Discovery through the acquisitions by Pharmacia and Pfizer. After Sugen, Dr.Gishizky served as Chief Scientific Officer at Entelos, leading in silico pathway analysis R&D programs. Dr.Gishizky extensive expertise includes drug development, technology implementation, bioinformatics, translational clinical research at biotech startups and big pharmaceutical companies. Dr.Gishizky is an accomplished entrepreneur and serves as Partner at Strategic Opportunity Ventures since 2009. Dr.Gishizky business experiences also includes IPO, liaison with US government, FDA, non-profit and pharmaceutical organizations. Dr.Gishizky has published a number of scientific peer-reviewed papers and holds number of patents and patent applications.